Evidence map›Paper›PMID 30646590›Full record

ReviewNutrients2019

Vitamin K in Chronic Kidney Disease.

Mario Cozzolino, Michela Mangano, Andrea Galassi, Paola Ciceri, Piergiorgio Messa, Sagar Nigwekar

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02278692 (Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02278692 nacompletednot on this map

Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy

TypeinterventionalSponsorMassachusetts General HospitalRan2015 to 2019Enrolled26ConditionsCalciphylaxis, Calcific Uremic ArteriolopathyArmsVitamin K, Placebo
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. The Role of Vitamin K in CKD-MBD.Current osteoporosis reports · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mario CozzolinoRenal Division, Department of Health Sciences, University of Milan, 20142 Milan, Italy. mario.cozzolino@unimi.it.ORCID 0000-0002-8494-6252
Michela ManganoRenal Division, Department of Health Sciences, University of Milan, 20142 Milan, Italy. michelamangano91@gmail.com.
Andrea GalassiRenal Division, Department of Health Sciences, University of Milan, 20142 Milan, Italy. andrea.galassi@asst-santipaolocarlo.it.
Paola CiceriRenal Research Laboratory, Department of Nephrology, Dialysis and Renal Transplant, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico & Fondazione D'Amico per la Ricerca sulle Malattie Renali, 20122 Milan, Italy. p.ciceri@hotmail.it.
Piergiorgio MessaRenal Research Laboratory, Department of Nephrology, Dialysis and Renal Transplant, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico & Fondazione D'Amico per la Ricerca sulle Malattie Renali, 20122 Milan, Italy. piergiorgio.messa@unimi.it.
Sagar NigwekarDepartment of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA 02114, USA. SNIGWEKAR@mgh.harvard.edu.ORCID 0000-0002-6750-0072
University of Milan · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin K is a composite term referring to a group of fat-soluble vitamins that function as a cofactor for the enzyme γ-glutamyl carboxylase (GGCX), which activates a number of vitamin K-dependent proteins (VKDPs) involved in haemostasis and vascular and bone health. Accumulating evidence demonstrates that chronic kidney disease (CKD) patients suffer from subclinical vitamin K deficiency, suggesting that this represents a population at risk for the biological consequences of poor vitamin K status. This deficiency might be caused by exhaustion of vitamin K due to its high requirements by vitamin K-dependent proteins to inhibit calcification.

Indexed as

Bone and BonesCarbon-Carbon LigasesDietary SupplementsHumansNutritional StatusRandomized Controlled Trials as TopicRenal Insufficiency, ChronicVitamin KVitamin K DeficiencyWarfarinCarbon-Carbon Ligasesglutamyl carboxylaseVitamin KWarfarinvitamin K, CKD, vascular calcification

Identifiers

PMID30646590
PMCPMC6356438
OpenAlexW2909064380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.